Entolimod for Vaccine Augmentation
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Entolimod (Primary) ; Diphtheria-tetanus vaccine
- Indications Drug abuse
- Focus Adverse reactions
- 20 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2018 Planned End Date changed from 1 Apr 2018 to 1 Dec 2019.
- 16 Jan 2018 Status changed from not yet recruiting to recruiting.